Puricelli Chiara, Rolla Roberta, Gigliotti Luca, Boggio Elena, Beltrami Eleonora, Dianzani Umberto, Keller Roberto
Department of Health Sciences, Università del Piemonte Orientale, Novara, Italy.
Clinical Biochemistry Laboratory, Ospedale Maggiore della Carità, Novara, Italy.
Front Psychiatry. 2022 Feb 3;12:755171. doi: 10.3389/fpsyt.2021.755171. eCollection 2021.
The interest elicited by the large microbial population colonizing the human gut has ancient origins and has gone through a long evolution during history. However, it is only in the last decades that the introduction of high-throughput technologies has allowed to broaden this research field and to disentangle the numerous implications that gut microbiota has in health and disease. This comprehensive ecosystem, constituted mainly by bacteria but also by fungi, parasites, and viruses, is proven to be involved in several physiological and pathological processes that transcend the intestinal homeostasis and are deeply intertwined with apparently unrelated body systems, such as the immune and the nervous ones. In this regard, a novel speculation is the relationship between the intestinal microbial flora and the pathogenesis of some neurological and neurodevelopmental disorders, including the clinical entities defined under the umbrella term of autism spectrum disorders. The bidirectional interplay has led researchers to coin the term gut-brain-immune system axis, subverting the theory of the brain as an immune-privileged site and underscoring the importance of this reciprocal influence already from fetal life and especially during the pre- and post-natal neurodevelopmental process. This revolutionary theory has also unveiled the possibility to modify the gut microbiota as a way to treat and even to prevent different kinds of pathologies. In this sense, some attempts have been made, ranging from probiotic administration to fecal microbiota transplantation, with promising results that need further elaboration. This state-of-art report will describe the main aspects regarding the human gut microbiome and its specific role in the pathogenesis of autism and its related disorders, with a final discussion on the therapeutic and preventive strategies aiming at creating a healthy intestinal microbial environment, as well as their safety and ethical implications.
人类肠道中大量微生物群落引发的关注由来已久,在历史进程中经历了漫长的演变。然而,直到最近几十年,高通量技术的引入才使得这一研究领域得以拓展,并厘清了肠道微生物群在健康和疾病方面的诸多影响。这个主要由细菌构成,但也包括真菌、寄生虫和病毒的综合生态系统,被证明参与了多种生理和病理过程,这些过程超越了肠道内环境稳定,与免疫和神经等明显不相关的身体系统紧密相连。在这方面,一个新的推测是肠道微生物群与某些神经和神经发育障碍的发病机制之间的关系,包括在自闭症谱系障碍这一统称下定义的临床实体。这种双向相互作用促使研究人员创造了“肠-脑-免疫系统轴”这一术语,颠覆了大脑是免疫豁免部位的理论,并凸显了这种相互影响从胎儿期就已存在的重要性,尤其是在产前和产后神经发育过程中。这一革命性理论还揭示了通过改变肠道微生物群来治疗甚至预防不同类型疾病的可能性。从这个意义上说,已经进行了一些尝试,从益生菌给药到粪便微生物群移植,取得了有前景的结果,但仍需进一步阐述。本前沿报告将描述人类肠道微生物组的主要方面及其在自闭症及其相关疾病发病机制中的具体作用,最后讨论旨在营造健康肠道微生物环境的治疗和预防策略,以及它们的安全性和伦理意义。